Drugmaker Pfizer hid that one of its powerful anti-inflammatory drugs for rheumatoid arthritis therapy, Enbrel, reduced the risk of Alzheimer’s disease by 64%, according to a report by the Washington Post.

The U.S. Pharmacopeia (USP) has published a new chapter on the minimum standards required to prepare, compound, dispense and repackage both sterile and non-sterile radiopharmaceuticals associated with state-licensed activities.

Partners HealthCare, a Boston-based health system, has backed out of its planned acquisition of Care New England

Amid an ongoing court review of its $69 billion merger with health insurer Aetna, CVS Health isn’t slowing down in its plans to expand, according to executives who spoke at the company’s investor day on June 4.

Brand-name drugs are likely to keep rising in price, even though the top-selling ones have been available for years and have already seen their costs skyrocket, according to a new study published in JAMA.

The U.S. Nuclear Regulatory Commission (NRC) is considering changing training and experience requirements for administering radiopharmaceuticals that require a written directive.

CVS Health is gearing up to defend its $69 billion takeover of the nation’s third-largest health insurer, Aetna, The Wall Street Journal reported.

The most important financial problem American families face is healthcare costs, according to a new Gallup poll.